Michael Quangminh Truong1, Andrew Viggo Metcalfe2, Christopher Dillon Ovenden3, Timothy John Kleinig4,5, Christen David Barras6,7,8. 1. Department of Radiology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Michael.truong@sa.gov.au. 2. School of Mathematical Sciences, The University of Adelaide, Adelaide, South Australia, Australia. 3. Faculty of Health and Medical Sciences, Surgical Specialties, The University of Adelaide, Adelaide, South Australia, Australia. 4. Department of Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 5. Department of Medicine, The University of Adelaide, Adelaide, South Australia, Australia. 6. Department of Radiology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 7. South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. 8. The University of Adelaide, Adelaide, South Australia, Australia.
Abstract
PURPOSE: To assess the association between non-contrast computed tomography (NCCT) hematoma markers and the dynamic spot sign on computed tomography perfusion (CTP), and their associations with hematoma expansion, clinical outcome, and in-hospital mortality. METHODS: Patients who presented with intracerebral hemorrhage (ICH) to a stroke center over an 18-month period and underwent baseline NCCT and CTP, and a follow-up NCCT within 24 h after the baseline scan were included. The initial and follow-up hematoma volumes were calculated. Two raters independently assessed the baseline NCCT for hematoma markers and concurrently assessed the CTP for the dynamic spot sign. Univariate and multivariate logistic regression analyses were performed to assess the association between the hematoma markers and the dynamic spot sign, adjusting for known ICH expansion predictors. RESULTS: Eighty-five patients were included in our study and 55 patients were suitable for expansion analysis. Heterogeneous density was the only NCCT hematoma marker to be associated with the dynamic spot sign after multivariate analysis (odds ratio, 58.61; 95% confidence interval, 9.13-376.05; P < 0.001). The dynamic spot sign was present in 22 patients (26%) and significantly predicted hematoma expansion (odds ratio, 36.6; 95% confidence interval, 2.51-534.2; P = 0.008). All patients with a spot sign had a swirl sign. A co-located hypodensity and spot sign was significantly associated with in-hospital mortality (odds ratio, 6.17; 95% confidence interval, 1.09-34.78; P = 0.039). CONCLUSION: Heterogeneous density and swirl sign are associated with the dynamic spot sign. The dynamic spot sign is a stronger predictor than NCCT hematoma markers of significant hematoma expansion. A co-located spot sign and hypodensity predicts in-hospital mortality.
PURPOSE: To assess the association between non-contrast computed tomography (NCCT) hematoma markers and the dynamic spot sign on computed tomography perfusion (CTP), and their associations with hematoma expansion, clinical outcome, and in-hospital mortality. METHODS: Patients who presented with intracerebral hemorrhage (ICH) to a stroke center over an 18-month period and underwent baseline NCCT and CTP, and a follow-up NCCT within 24 h after the baseline scan were included. The initial and follow-up hematoma volumes were calculated. Two raters independently assessed the baseline NCCT for hematoma markers and concurrently assessed the CTP for the dynamic spot sign. Univariate and multivariate logistic regression analyses were performed to assess the association between the hematoma markers and the dynamic spot sign, adjusting for known ICH expansion predictors. RESULTS: Eighty-five patients were included in our study and 55 patients were suitable for expansion analysis. Heterogeneous density was the only NCCT hematoma marker to be associated with the dynamic spot sign after multivariate analysis (odds ratio, 58.61; 95% confidence interval, 9.13-376.05; P < 0.001). The dynamic spot sign was present in 22 patients (26%) and significantly predicted hematoma expansion (odds ratio, 36.6; 95% confidence interval, 2.51-534.2; P = 0.008). All patients with a spot sign had a swirl sign. A co-located hypodensity and spot sign was significantly associated with in-hospital mortality (odds ratio, 6.17; 95% confidence interval, 1.09-34.78; P = 0.039). CONCLUSION: Heterogeneous density and swirl sign are associated with the dynamic spot sign. The dynamic spot sign is a stronger predictor than NCCT hematoma markers of significant hematoma expansion. A co-located spot sign and hypodensity predicts in-hospital mortality.
Authors: Andrew M Demchuk; Dar Dowlatshahi; David Rodriguez-Luna; Carlos A Molina; Yolanda Silva Blas; Imanuel Dzialowski; Adam Kobayashi; Jean-Martin Boulanger; Cheemun Lum; Gord Gubitz; Vasantha Padma; Jayanta Roy; Carlos S Kase; Jayme Kosior; Rohit Bhatia; Sarah Tymchuk; Suresh Subramaniam; David J Gladstone; Michael D Hill; Richard I Aviv Journal: Lancet Neurol Date: 2012-03-08 Impact factor: 44.182
Authors: S M Davis; J Broderick; M Hennerici; N C Brun; M N Diringer; S A Mayer; K Begtrup; T Steiner Journal: Neurology Date: 2006-04-25 Impact factor: 9.910
Authors: Andrea Morotti; Gregoire Boulouis; Dar Dowlatshahi; Qi Li; Christen D Barras; Candice Delcourt; Zhiyuan Yu; Jun Zheng; Zien Zhou; Richard I Aviv; Ashkan Shoamanesh; Peter B Sporns; Jonathan Rosand; Steven M Greenberg; Rustam Al-Shahi Salman; Adnan I Qureshi; Andrew M Demchuk; Craig S Anderson; Joshua N Goldstein; Andreas Charidimou Journal: Ann Neurol Date: 2019-08-24 Impact factor: 10.422
Authors: Gregoire Boulouis; Andrea Morotti; H Bart Brouwers; Andreas Charidimou; Michael J Jessel; Eitan Auriel; Octávio Pontes-Neto; Alison Ayres; Anastasia Vashkevich; Kristin M Schwab; Jonathan Rosand; Anand Viswanathan; Mahmut E Gurol; Steven M Greenberg; Joshua N Goldstein Journal: JAMA Neurol Date: 2016-08-01 Impact factor: 18.302
Authors: Christen D Barras; Brian M Tress; Soren Christensen; Lachlan MacGregor; Marnie Collins; Patricia M Desmond; Brett E Skolnick; Stephan A Mayer; Joseph P Broderick; Michael N Diringer; Thorsten Steiner; Stephen M Davis Journal: Stroke Date: 2009-03-12 Impact factor: 7.914
Authors: H Bart Brouwers; Yuchiao Chang; Guido J Falcone; Xuemei Cai; Alison M Ayres; Thomas W K Battey; Anastasia Vashkevich; Kristen A McNamara; Valerie Valant; Kristin Schwab; Susannah C Orzell; Linda M Bresette; Steven K Feske; Natalia S Rost; Javier M Romero; Anand Viswanathan; Sherry H-Y Chou; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein Journal: JAMA Neurol Date: 2014-02 Impact factor: 18.302
Authors: Rustam Al-Shahi Salman; Joseph Frantzias; Robert J Lee; Patrick D Lyden; Thomas W K Battey; Alison M Ayres; Joshua N Goldstein; Stephan A Mayer; Thorsten Steiner; Xia Wang; Hisatomi Arima; Hitoshi Hasegawa; Makoto Oishi; Daniel A Godoy; Luca Masotti; Dar Dowlatshahi; David Rodriguez-Luna; Carlos A Molina; Dong-Kyu Jang; Antonio Davalos; José Castillo; Xiaoying Yao; Jan Claassen; Bastian Volbers; Seiji Kazui; Yasushi Okada; Shigeru Fujimoto; Kazunori Toyoda; Qi Li; Jane Khoury; Pilar Delgado; José Álvarez Sabín; Mar Hernández-Guillamon; Luis Prats-Sánchez; Chunyan Cai; Mahesh P Kate; Rebecca McCourt; Chitra Venkatasubramanian; Michael N Diringer; Yukio Ikeda; Hans Worthmann; Wendy C Ziai; Christopher D d'Esterre; Richard I Aviv; Peter Raab; Yasuo Murai; Allyson R Zazulia; Kenneth S Butcher; Seyed Mohammad Seyedsaadat; James C Grotta; Joan Martí-Fàbregas; Joan Montaner; Joseph Broderick; Haruko Yamamoto; Dimitre Staykov; E Sander Connolly; Magdy Selim; Rogelio Leira; Byung Hoo Moon; Andrew M Demchuk; Mario Di Napoli; Yukihiko Fujii; Craig S Anderson; Jonathan Rosand Journal: Lancet Neurol Date: 2018-08-14 Impact factor: 44.182